In another model of chronic Ang II-dependent hypertension, using a lower dose of Ang II to produce a delayed increase in blood pressure (also known as a “slow-pressor” dose of Ang II), ROS levels in the vasculature are elevated (Capone et al., 2010, 2011, 2012). The gene discussed is AGT; the disease is substance dependence.